Joseph Miller

Joseph Miller

No open positions remaining

Net worth: 9 M $ as of 2026-05-30

52 year
Health Technology
Commercial Services
Consumer Services

Profile

Joseph M.
Miller
worked as Chief Financial Officer & Vice President-Finance at Eppendorf, Inc. and Eppendorf-5 Prime, Inc. from 2002 to 2006.
From 2006 to 2015, Mr. Miller was Senior Director-Accounting at Qiagen Genomics, Inc. and QIAGEN NV.
Between 2015 and 2018, Mr. Miller served as Vice President-Finance at Sucampo Pharmaceuticals LLC.
From 2020 to 2022, Mr. Miller was Director at Avalo Therapeutics, Inc. Mr. Miller's education includes an undergraduate degree from Villanova University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-03-01 576,421 ( 0.45% ) 9 M $ 2026-05-30

Former positions of Joseph Miller

CompaniesPositionEnd
AURINIA PHARMACEUTICALS INC. Director of Finance/CFO 2026-03-19
AVALO THERAPEUTICS, INC. Director of Finance/CFO 2020-04-23
SUCAMPO PHARMACEUTICALS, INC. Director of Finance/CFO 2018-03-31
Comptroller/Controller/Auditor 2014-12-31
QIAGEN N.V. Comptroller/Controller/Auditor 2014-12-31
See the detail of Joseph Miller's experience

Training of Joseph Miller

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

53

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Health Technology

Health Technology

Commercial Services

Consumer Services

Health Technology

Eppendorf-5 Prime, Inc.

Health Technology

Health Technology